|
USP22 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.024770E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.141600E-03 |
| Normal-vs-Stage2 |
5.997000E-01 |
| Normal-vs-Stage3 |
1.622720E-04 |
| Normal-vs-Stage4 |
1.65326000000077E-05 |
| Stage1-vs-Stage2 |
3.731700E-02 |
| Stage1-vs-Stage3 |
1.934580E-01 |
| Stage1-vs-Stage4 |
1.156440E-02 |
| Stage2-vs-Stage3 |
3.419800E-03 |
| Stage2-vs-Stage4 |
4.808200E-04 |
| Stage3-vs-Stage4 |
2.313200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.751300E-04 |
| Normal-vs-AfricanAmerican |
4.061800E-01 |
| Normal-vs-Asian |
5.900400E-02 |
| Caucasian-vs-AfricanAmerican |
1.479190E-01 |
| Caucasian-vs-Asian |
4.311600E-01 |
| AfricanAmerican-vs-Asian |
5.027400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.019870E-03 |
| Normal-vs-Female |
2.181200E-03 |
| Male-vs-Female |
5.319000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.716800E-03 |
| Normal-vs-Age(41-60Yrs) |
3.661200E-03 |
| Normal-vs-Age(61-80Yrs) |
3.78790000000739E-05 |
| Normal-vs-Age(81-100Yrs) |
3.811600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.681800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.551500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.694800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.794790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.688000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.954400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.739800E-03 |
| Classical-VS-Follicular |
3.261000E-01 |
| Classical-VS-Other |
1.017030E-01 |
| Classical-VS-Normal |
1.038040E-02 |
| Tall-VS-Follicular |
4.266100E-02 |
| Tall-VS-Other |
8.143400E-01 |
| Tall-VS-Normal |
5.89129999999383E-05 |
| Follicular-VS-Other |
2.697200E-01 |
| Follicular-VS-Normal |
8.921500E-03 |
| Other-VS-Normal |
1.440230E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.743000E-03 |
| Normal-vs-N1 |
4.38709999994735E-06 |
| N0-vs-N1 |
8.880800E-03 |
|
|
